Literature DB >> 16376248

Perioperative morbidity and 30-day mortality after intertrochanteric hip fractures treated by internal fixation or arthroplasty.

Ryan E Dobbs1, Javad Parvizi, David G Lewallen.   

Abstract

The conventional treatment for intertrochanteric hip fracture is open reduction and internal fixation. However, hip arthroplasty is occasionally performed. The objective of this study was to determine the 30-day mortality for patients with intertrochanteric hip fracture treated with open reduction, internal fixation, or hip arthroplasty. The mortality rate for patients treated with arthroplasty at 4.8% (23/478) was slightly, but not significantly, higher than that for patients treated with open reduction and internal fixation at 4.5% (62/1395). However, more of the patients in the arthroplasty group exhibited serious intraoperative cardiorespiratory disturbances (62% vs 22%) and died in the hospital (77% vs 35%) when compared with the patients in the open reduction and internal fixation group. Although the incidence of 30-day mortality in these groups was not significantly different, the patients in the arthroplasty group were more likely to have a complicated intraoperative course and die in the hospital.

Entities:  

Mesh:

Year:  2005        PMID: 16376248     DOI: 10.1016/j.arth.2005.04.035

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  14 in total

Review 1.  Review article: Patient characteristics that act as risk factors for intraoperative complications in hip, knee, and shoulder arthroplasties.

Authors:  Adel Hijazi; Muhammad Talha Padela; Zain Sayeed; Aws Hammad; Kamela Devole; Todd Frush; Gamal Mostafa; Walid K Yassir; Khaled J Saleh
Journal:  J Orthop       Date:  2019-06-17

2.  Treatment of femoral subtrochanteric fractures with proximal lateral femur locking plates.

Authors:  Sun-Jun Hu; Shi-Min Zhang; Guang-Rong Yu
Journal:  Acta Ortop Bras       Date:  2012-12       Impact factor: 0.513

3.  Analysis of factors among 30-day and 1-year mortality rates in patients with borderline stable-unstable intertrochanteric hip fracture.

Authors:  İbrahim Deniz Canbeyli; Meriç Çırpar; Birhan Oktaş; Mehmet Çoban
Journal:  Acta Orthop Traumatol Turc       Date:  2021-01       Impact factor: 1.511

4.  Evaluation of proximal femoral locking plate in unstable extracapsular proximal femoral fractures: Surgical technique & mid term follow up results.

Authors:  Nishikant Kumar; Himanshu Kataria; Chandrashekhar Yadav; Bharath S Gadagoli; Rishi Raj
Journal:  J Clin Orthop Trauma       Date:  2014-09-10

5.  Length of stay, wait time to surgery and 30-day mortality for patients with hip fractures after the opening of a dedicated orthopedic weekend trauma room.

Authors:  Michel Taylor; Wilma Hopman; Jeff Yach
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

6.  Safety and reliability of external fixation for basicervical and intertrochanteric fractures in high-risk elderly patients.

Authors:  George W Boghdady; Mohammed Shalaby
Journal:  Strategies Trauma Limb Reconstr       Date:  2007-12-05

7.  Primary prosthetic replacement in per- and intertrochanteric fractures.

Authors:  M Hoffmann; M Hartel; J M Rueger; W Lehmann
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-03       Impact factor: 3.693

8.  A retrospective analysis of surgically-treated complex proximal femur fractures with proximal femoral locking compression plate.

Authors:  Syed Ibrahim; Jimmy Joseph Meleppuram
Journal:  Rev Bras Ortop       Date:  2017-01-07

9.  Trochanteric fractures in the elderly: the influence of primary hip arthroplasty on 1-year mortality.

Authors:  Florian Geiger; Monique Zimmermann-Stenzel; Christian Heisel; Burkhard Lehner; Wolfgang Daecke
Journal:  Arch Orthop Trauma Surg       Date:  2007-12       Impact factor: 3.067

10.  Cemented Hemiarthroplasty in Elderly Osteoporotic Unstable Trochanteric Fractures using Fracture Window.

Authors:  A Thakur; M Lal
Journal:  Malays Orthop J       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.